Results 211 to 220 of about 2,439,563 (414)

Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participants

, 2022
Zonglin Li, Lin Chu, Jinyu Zhou, Xiaoling Cai, Xingyun Zhu, Suiyuan Hu, Fang Lv, Wenjia Yang, Linong Ji   +8 more
openalex   +1 more source

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2018
W. Koh, N. Abu-Rustum, S. Bean, K. Bradley, S. Campos, Kathleen R. Cho, H. Chon, C. Chu, D. Cohn, M. Crispens, S. Damast, O. Dorigo, P. Eifel, C. Fisher, P. Frederick, D. Gaffney, S. George, E. Han, S. Higgins, W. Huh, J. Lurain, A. Mariani, D. Mutch, C. Nagel, L. Nekhlyudov, A. Fader, S. Remmenga, R. Reynolds, T. Tillmanns, S. Ueda, E. Wyse, C. Yashar, Nicole R Mcmillian, Jillian L. Scavone   +33 more
semanticscholar   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

Molecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, Mara S Serafini, Qiang Zhang, Youbin Zhang, Lorenzo Gerratana, Andrew A. Davis, Huiping Liu, William J Gradishar, Carolina Reduzzi, Massimo Cristofanilli, Evi Lianidou   +12 more
wiley   +1 more source

Are thrombosis, progression, and survival in ET predictable?

Blood Cancer Journal
Ghaith Abu-Zeinah, Katie Erdos, Neville Lee, Ahamed Lebbe, Imane Bouhali, Mohammed Khalid, Richard T. Silver, Joseph M. Scandura   +7 more
doaj   +1 more source

Homologous recombination repair germline variants and subsequent neoplasm risk among childhood cancer survivors. [PDF]

JNCI Cancer Spectr
Zamani SA, Karyadi DM, Hartley SW, Gibson TM, Sampson JN, Kraft P, Chanock SJ, Morton LM.   +7 more
europepmc   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

Porous polyethylene in reconstructive head and neck surgery [PDF]

, 1985
Berghaus, Alexander
core   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Multiple malignant primary tumors in dogs: an Italian registry-based epidemiological study. [PDF]

Front Vet Sci
Crescio MI, Cocumelli C, Carnio A, Carvelli A, Fonti N, Garcia-Vozmediano A, Galietta V, Eleni C, Ingravalle F, Manuali E, Maresca C, Millanta F, Razzuoli E, Scaramozzino P, Simeoni S, Vascellari M, Zanardello C, Ru G.   +17 more
europepmc   +1 more source

Neutralize the neutrophils! Neutrophil β1 /β2 integrin activation contributes to JAK2-V617F–driven thrombosis [PDF]

, 2018
Barbui, De Stefano, Sands, Stephen T. Oh, Wolach   +4 more
core   +2 more sources